Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04003363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The United Kingdom National Registry for Myotonic Dystrophy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Publications: details revised at 4 of 4 entries Eligibility criteria expanded, about 2 words · Study description expanded, about 2 words Show 2 more changesShow less
    • Eligibility criteria expanded, about 2 words
    • Study description expanded, about 2 words
  2. Enrollment target: 785 to 900 Study description shortened, about 16 wordsv4 Show 1 more changeShow less
    • Study description shortened, about 16 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Dec 2021 to Jan 2030 Start date: May 2012 to May 2013 · Completion date: Dec 2021 to Dec 2030 · Site contact updatedv3 Show 3 more changesShow less
    • Start date: May 2012 to May 2013
    • Completion date: Dec 2021 to Dec 2030
    • Site contact updated
  4. Primary and study completion dates: Dec 2020 to Dec 2021 Enrollment target: 750 to 785v2 Show 1 more changeShow less
    • Enrollment target: 750 to 785
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Myotonic dystrophy (dystrophia myotonica - DM) exists in two forms, usually referred to as DM1 (type 1) and DM2 (type 2). Both conditions are genetic disorders but each affects a different gene. DM1 is the most common adult-onset muscular dystrophy, and is thought to affect at least 1 in 8,000 people worldwide. The aim is to facilitate a questionnaire based research study in order to better characterise and understand the disease in the UK. By maintaining a national registry this will help identify potential participants eligible for clinical trials in the future.
Trial Details
NCT Number NCT04003363
Lead Sponsor Newcastle University
Conditions Myotonic Dystrophy
Enrollment 900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov